li_item_id stringlengths 7 30 | drug_name stringlengths 4 169 | li_drug_name stringlengths 4 169 ⌀ | li_form stringlengths 8 210 ⌀ | schedule_form stringlengths 21 261 ⌀ | brand_name stringlengths 3 88 ⌀ | program_code stringclasses 17
values | pbs_code stringlengths 3 6 | benefit_type_code stringclasses 4
values | caution_indicator stringclasses 2
values | note_indicator stringclasses 2
values | manner_of_administration stringclasses 25
values | maximum_prescribable_pack float64 0.08 200 ⌀ | maximum_quantity_units float64 1 2.1k ⌀ | number_of_repeats float64 0 140 ⌀ | organisation_id float64 7 2.49k ⌀ | manufacturer_code stringclasses 226
values | pack_size float64 1 1k ⌀ | pricing_quantity float64 1 1k ⌀ | pack_not_to_be_broken_ind stringclasses 2
values | claimed_price float64 0.75 2.53M ⌀ | determined_price float64 0.75 2.53M ⌀ | determined_qty stringclasses 2
values | safety_net_resupply_rule_days float64 4 50 ⌀ | safety_net_resup_rule_cnt_ind stringclasses 2
values | extemporaneous_indicator stringclasses 2
values | extemporaneous_standard stringclasses 14
values | doctors_bag_group_id float64 1 62 ⌀ | section100_only_indicator stringclasses 2
values | doctors_bag_only_indicator stringclasses 2
values | brand_substitution_group_id float64 14.6k 29.7k ⌀ | brand_substitution_group_code stringclasses 2
values | supply_only_indicator stringclasses 2
values | supply_only_date stringclasses 9
values | non_effective_date stringclasses 3
values | weighted_avg_disclosed_price float64 | originator_brand_indicator stringclasses 2
values | paper_med_chart_eligible_ind stringclasses 2
values | elect_med_chart_eligible_ind stringclasses 2
values | hsptl_med_chart_eligible_ind stringclasses 2
values | paper_med_chart_duration float64 4 4 ⌀ | elect_med_chart_duration float64 6 6 ⌀ | hsptl_chart_acute_duration float64 12 12 ⌀ | hsptl_chart_sub_acute_duration float64 12 12 ⌀ | hsptl_chart_chronic_duration float64 12 12 ⌀ | pack_content float64 1 20k ⌀ | vial_content float64 1 15k ⌀ | infusible_indicator stringclasses 2
values | unit_of_measure stringclasses 6
values | continued_dispensing_flag stringclasses 2
values | continued_dispensing_emergency stringclasses 1
value | maximum_amount float64 2 30k ⌀ | formulary stringclasses 3
values | water_added_ind stringclasses 2
values | section_19a_expiry_date stringclasses 16
values | container_fee_type stringclasses 2
values | policy_applied_imdq60_base_flag stringclasses 2
values | policy_applied_imdq60_flag stringclasses 2
values | policy_applied_bio_sim_up_flag stringclasses 1
value | policy_applied_indig_phar_flag stringclasses 2
values | therapeutic_exemption_indicator stringclasses 2
values | premium_exemption_group_id float64 1.34k 1.34k ⌀ | doctors_bag_group_title stringclasses 1
value | therapeutic_group_id float64 1.34k 1.34k ⌀ | therapeutic_group_title stringclasses 1
value | advanced_notice_date stringclasses 3
values | supply_only_end_date stringclasses 8
values | first_listed_date stringdate 1991-08-01 00:00:00 2025-05-01 00:00:00 ⌀ | legal_unar_ind stringclasses 2
values | legal_car_ind stringclasses 2
values | schedule_code int64 3.67k 3.67k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9665Q_7409_997_4691_57657 | Tacrolimus | Tacrolimus | Capsule 1 mg (once daily prolonged release) | tacrolimus 1 mg modified release capsule, 60 | Tacrolimus XR Sandoz | HB | 9665Q | S | Y | N | ORAL | 2 | 120 | 5 | 90 | SZ | 60 | 60 | N | 61.78 | 61.78 | N | 20 | N | N | null | null | N | N | 20,891 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2024-05-01 | N | N | 3,671 |
9666R_12306_997_4693_40655 | Tacrolimus | Tacrolimus | Capsule 5 mg (once daily prolonged release) | tacrolimus 5 mg modified release capsule, 30 | ADVAGRAF XL | HB | 9666R | S | Y | N | ORAL | 2 | 60 | 5 | 677 | LQ | 30 | 30 | N | 375.22 | 375.22 | N | 20 | N | N | null | null | N | N | 20,887 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-08-01 | N | N | 3,671 |
9666R_12306_997_4693_57659 | Tacrolimus | Tacrolimus | Capsule 5 mg (once daily prolonged release) | tacrolimus 5 mg modified release capsule, 30 | Tacrolimus XR Sandoz | HB | 9666R | S | Y | N | ORAL | 2 | 60 | 5 | 90 | SZ | 30 | 30 | N | 375.22 | 375.22 | N | 20 | N | N | null | null | N | N | 20,887 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2024-05-01 | N | N | 3,671 |
9667T_12342_1227_5503_6625 | Thalidomide | Thalidomide | Capsule 100 mg | thalidomide 100 mg capsule, 28 | Thalomid | HB | 9667T | S | Y | Y | ORAL | 2 | 56 | 0 | 45 | BQ | 28 | 28 | N | 530.69 | 530.69 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2010-11-01 | N | N | 3,671 |
9668W_10878_1384_5915_7204 | epoetin lambda | Epoetin lambda | Injection 1,000 units in 0.5 mL pre-filled syringe | epoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes | Novicrit | HB | 9668W | S | N | N | INJECTION | 2 | 12 | 5 | 90 | SZ | 6 | 6 | N | 113.12 | 113.12 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-12-01 | N | N | 3,671 |
9669X_8856_1384_5917_7206 | epoetin lambda | Epoetin lambda | Injection 2,000 units in 1 mL pre-filled syringe | epoetin lambda 2000 units/mL injection, 6 x 1 mL syringes | Novicrit | HB | 9669X | S | N | N | INJECTION | 2 | 12 | 5 | 90 | SZ | 6 | 6 | N | 209.3 | 209.3 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-12-01 | N | N | 3,671 |
9670Y_10879_1384_5918_7207 | epoetin lambda | Epoetin lambda | Injection 3,000 units in 0.3 mL pre-filled syringe | epoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes | Novicrit | HB | 9670Y | S | N | N | INJECTION | 2 | 12 | 5 | 90 | SZ | 6 | 6 | N | 270.1 | 270.1 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-12-01 | N | N | 3,671 |
9671B_12337_1373_5891_7177 | Tocilizumab | Tocilizumab | Concentrate for injection 80 mg in 4 mL | tocilizumab 80 mg/4 mL injection, 4 mL vial | Actemra | HS | 9671B | A | N | Y | INJECTION | 1 | 1 | 0 | 102 | RO | 1 | 1 | N | 82.19 | 82.19 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-08-01 | N | Y | 3,671 |
9672C_8853_1373_5889_7175 | Tocilizumab | Tocilizumab | Concentrate for injection 200 mg in 10 mL | tocilizumab 200 mg/10 mL injection, 10 mL vial | Actemra | HS | 9672C | A | N | Y | INJECTION | 1 | 1 | 0 | 102 | RO | 1 | 1 | N | 203.73 | 203.73 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-08-01 | N | Y | 3,671 |
9673D_8855_1373_5890_7176 | Tocilizumab | Tocilizumab | Concentrate for injection 400 mg in 20 mL | tocilizumab 400 mg/20 mL injection, 20 mL vial | Actemra | HS | 9673D | A | N | Y | INJECTION | 1 | 1 | 0 | 102 | RO | 1 | 1 | N | 405.39 | 405.39 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-08-01 | N | Y | 3,671 |
9674E_11574_1167_5317_38268 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Inflectra | HS | 9674E | A | N | Y | INJECTION | 1 | 1 | 0 | 69 | PF | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,382 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-12-01 | N | Y | 3,671 |
9674E_11574_1167_5317_41027 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Renflexis | HS | 9674E | A | N | Y | INJECTION | 1 | 1 | 0 | 1,829 | OQ | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,382 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2017-08-01 | N | Y | 3,671 |
9674E_11574_1167_5317_6278 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Remicade | HS | 9674E | A | N | Y | INJECTION | 1 | 1 | 0 | 63 | JC | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,382 | a | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-08-01 | N | Y | 3,671 |
9675F_8141_1155_5292_6244 | Valganciclovir | Valganciclovir | Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL | valganciclovir 50 mg/mL powder for oral liquid, 100 mL | Valcyte | HS | 9675F | S | N | N | ORAL | 11 | 11 | 5 | 817 | PB | 1 | 1 | N | 395.1 | 395.1 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | Y | null | other | N | N | N | N | N | null | null | null | null | null | null | 2010-08-01 | N | N | 3,671 |
9679K_10037_1189_5419_45576 | Adalimumab | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes | Hadlima | HS | 9679K | A | N | Y | INJECTION | 1 | 2 | 0 | 1,081 | RF | 2 | 2 | N | 505.95 | 505.95 | N | 4 | N | N | null | null | N | N | 25,128 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2021-04-01 | N | Y | 3,671 |
9679K_10037_1189_5419_45951 | Adalimumab | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes | Amgevita | HS | 9679K | A | N | Y | INJECTION | 1 | 2 | 0 | 1,908 | XT | 2 | 2 | N | 505.95 | 505.95 | N | 4 | N | N | null | null | N | N | 25,128 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2021-04-01 | N | Y | 3,671 |
9679K_10037_1189_5419_49269 | Adalimumab | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes | Hyrimoz | HS | 9679K | A | N | Y | INJECTION | 1 | 2 | 0 | 90 | SZ | 2 | 2 | N | 505.95 | 505.95 | N | 4 | N | N | null | null | N | N | 25,128 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2021-04-01 | N | Y | 3,671 |
9679K_10037_1189_5419_54287 | Adalimumab | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes | Abrilada | HS | 9679K | A | N | Y | INJECTION | 1 | 2 | 0 | 69 | PF | 2 | 2 | N | 505.95 | 505.95 | N | 4 | N | N | null | null | N | N | 25,128 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2024-08-01 | N | Y | 3,671 |
9680L_7270_1189_5417_49267 | Adalimumab | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Hyrimoz | HS | 9680L | A | N | Y | INJECTION | 1 | 2 | 0 | 90 | SZ | 2 | 2 | N | 505.95 | 505.95 | N | 4 | N | N | null | null | N | N | 25,112 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2021-04-01 | N | Y | 3,671 |
9680L_7270_1189_5417_50918 | Adalimumab | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Hadlima | HS | 9680L | A | N | Y | INJECTION | 1 | 2 | 0 | 1,081 | RF | 2 | 2 | N | 505.95 | 505.95 | N | 4 | N | N | null | null | N | N | 25,112 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2021-04-01 | N | Y | 3,671 |
9680L_7270_1189_5417_51588 | Adalimumab | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Amgevita | HS | 9680L | A | N | Y | INJECTION | 1 | 2 | 0 | 1,908 | XT | 2 | 2 | N | 505.95 | 505.95 | N | 4 | N | N | null | null | N | N | 25,112 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2021-04-01 | N | Y | 3,671 |
9680L_7270_1189_5417_54286 | Adalimumab | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices | Abrilada | HS | 9680L | A | N | Y | INJECTION | 1 | 2 | 0 | 69 | PF | 2 | 2 | N | 505.95 | 505.95 | N | 4 | N | N | null | null | N | N | 25,112 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2024-08-01 | N | Y | 3,671 |
9681M_7408_997_4689_40651 | Tacrolimus | Tacrolimus | Capsule 0.5 mg (once daily prolonged release) | tacrolimus 500 microgram modified release capsule, 30 | ADVAGRAF XL | HS | 9681M | S | Y | N | ORAL | 2 | 60 | 5 | 677 | LQ | 30 | 30 | N | 37.52 | 37.52 | N | 20 | N | N | null | null | N | N | 20,892 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-08-01 | N | N | 3,671 |
9681M_7408_997_4689_57660 | Tacrolimus | Tacrolimus | Capsule 0.5 mg (once daily prolonged release) | tacrolimus 500 microgram modified release capsule, 30 | Tacrolimus XR Sandoz | HS | 9681M | S | Y | N | ORAL | 2 | 60 | 5 | 90 | SZ | 30 | 30 | N | 37.52 | 37.52 | N | 20 | N | N | null | null | N | N | 20,892 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2024-05-01 | N | N | 3,671 |
9682N_7409_997_4691_40653 | Tacrolimus | Tacrolimus | Capsule 1 mg (once daily prolonged release) | tacrolimus 1 mg modified release capsule, 60 | ADVAGRAF XL | HS | 9682N | S | Y | N | ORAL | 2 | 120 | 5 | 677 | LQ | 60 | 60 | N | 61.78 | 61.78 | N | 20 | N | N | null | null | N | N | 20,907 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-08-01 | N | N | 3,671 |
9682N_7409_997_4691_57657 | Tacrolimus | Tacrolimus | Capsule 1 mg (once daily prolonged release) | tacrolimus 1 mg modified release capsule, 60 | Tacrolimus XR Sandoz | HS | 9682N | S | Y | N | ORAL | 2 | 120 | 5 | 90 | SZ | 60 | 60 | N | 61.78 | 61.78 | N | 20 | N | N | null | null | N | N | 20,907 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2024-05-01 | N | N | 3,671 |
9683P_12306_997_4693_40655 | Tacrolimus | Tacrolimus | Capsule 5 mg (once daily prolonged release) | tacrolimus 5 mg modified release capsule, 30 | ADVAGRAF XL | HS | 9683P | S | Y | N | ORAL | 2 | 60 | 5 | 677 | LQ | 30 | 30 | N | 375.22 | 375.22 | N | 20 | N | N | null | null | N | N | 20,896 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-08-01 | N | N | 3,671 |
9683P_12306_997_4693_57659 | Tacrolimus | Tacrolimus | Capsule 5 mg (once daily prolonged release) | tacrolimus 5 mg modified release capsule, 30 | Tacrolimus XR Sandoz | HS | 9683P | S | Y | N | ORAL | 2 | 60 | 5 | 90 | SZ | 30 | 30 | N | 375.22 | 375.22 | N | 20 | N | N | null | null | N | N | 20,896 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2024-05-01 | N | N | 3,671 |
9684Q_12342_1227_5503_6625 | Thalidomide | Thalidomide | Capsule 100 mg | thalidomide 100 mg capsule, 28 | Thalomid | HS | 9684Q | S | Y | Y | ORAL | 2 | 56 | 0 | 45 | BQ | 28 | 28 | N | 530.69 | 530.69 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2010-11-01 | N | N | 3,671 |
9685R_10878_1384_5915_7204 | epoetin lambda | Epoetin lambda | Injection 1,000 units in 0.5 mL pre-filled syringe | epoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes | Novicrit | HS | 9685R | S | N | N | INJECTION | 2 | 12 | 5 | 90 | SZ | 6 | 6 | N | 113.12 | 113.12 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-12-01 | N | N | 3,671 |
9686T_8856_1384_5917_7206 | epoetin lambda | Epoetin lambda | Injection 2,000 units in 1 mL pre-filled syringe | epoetin lambda 2000 units/mL injection, 6 x 1 mL syringes | Novicrit | HS | 9686T | S | N | N | INJECTION | 2 | 12 | 5 | 90 | SZ | 6 | 6 | N | 209.3 | 209.3 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-12-01 | N | N | 3,671 |
9687W_10879_1384_5918_7207 | epoetin lambda | Epoetin lambda | Injection 3,000 units in 0.3 mL pre-filled syringe | epoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes | Novicrit | HS | 9687W | S | N | N | INJECTION | 2 | 12 | 5 | 90 | SZ | 6 | 6 | N | 270.1 | 270.1 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-12-01 | N | N | 3,671 |
9688X_7441_1384_5919_7208 | epoetin lambda | Epoetin lambda | Injection 4,000 units in 0.4 mL pre-filled syringe | epoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes | Novicrit | HS | 9688X | S | N | N | INJECTION | 2 | 12 | 5 | 90 | SZ | 6 | 6 | N | 343.97 | 343.97 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2010-12-01 | N | N | 3,671 |
9696H_9526_1393_5934_7224 | Romiplostim | Romiplostim | Powder for injection 375 micrograms | romiplostim 250 microgram injection, 1 vial | Nplate | HB | 9696H | A | N | Y | INJECTION | 1 | 1 | 5 | 43 | AN | 1 | 1 | N | 494.12 | 494.12 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2011-04-01 | N | Y | 3,671 |
9697J_9526_1393_5934_7224 | Romiplostim | Romiplostim | Powder for injection 375 micrograms | romiplostim 250 microgram injection, 1 vial | Nplate | HS | 9697J | A | N | Y | INJECTION | 1 | 1 | 5 | 43 | AN | 1 | 1 | N | 494.12 | 494.12 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2011-04-01 | N | Y | 3,671 |
9698K_12343_1393_5935_7225 | Romiplostim | Romiplostim | Powder for injection 625 micrograms | romiplostim 500 microgram injection, 1 vial | Nplate | HB | 9698K | A | N | Y | INJECTION | 1 | 1 | 5 | 43 | AN | 1 | 1 | N | 988.24 | 988.24 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2011-04-01 | N | Y | 3,671 |
9699L_12343_1393_5935_7225 | Romiplostim | Romiplostim | Powder for injection 625 micrograms | romiplostim 500 microgram injection, 1 vial | Nplate | HS | 9699L | A | N | Y | INJECTION | 1 | 1 | 5 | 43 | AN | 1 | 1 | N | 988.24 | 988.24 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2011-04-01 | N | Y | 3,671 |
9714G_11935_152_1533_8684 | Amoxicillin | Amoxicillin | Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL | amoxicillin 100 mg/mL powder for oral liquid, 20 mL | Amoxil | GE | 9714G | A | N | N | ORAL | 1 | 1 | 1 | 70 | AS | 1 | 1 | Y | 6.37 | 5.88 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | Y | null | null | N | N | N | N | Y | 1,336 | null | 1,336 | Pr Tgp Ospc Exception | null | null | 2006-10-01 | N | N | 3,671 |
9734H_12229_1049_4883_14411 | Naratriptan | Naratriptan | Tablet 2.5 mg (as hydrochloride) | naratriptan 2.5 mg tablet, 2 | Naramig | GE | 9734H | A | Y | Y | ORAL | 2 | 4 | 5 | 70 | AS | 2 | 2 | N | 5.69 | 4.98 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | Y | 1,336 | null | 1,336 | Pr Tgp Ospc Exception | null | null | 2007-04-01 | N | N | 3,671 |
9743T_9356_399_2488_8752 | Levodopa + carbidopa | Levodopa with carbidopa | Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg per mL, 100 mL | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL | Duodopa | HB | 9743T | S | N | Y | INTRA_INTESTINAL | 8 | 56 | 5 | 68 | VE | 7 | 7 | N | 1,442 | 1,442 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2011-05-01 | N | N | 3,671 |
9744W_9356_399_2488_8752 | Levodopa + carbidopa | Levodopa with carbidopa | Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg per mL, 100 mL | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL | Duodopa | HS | 9744W | S | N | Y | INTRA_INTESTINAL | 8 | 56 | 5 | 68 | VE | 7 | 7 | N | 1,442 | 1,442 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2011-05-01 | N | N | 3,671 |
9747B_7276_1184_5396_6477 | Sirolimus | Sirolimus | Tablet 0.5 mg | sirolimus 500 microgram tablet, 100 | Rapamune | HB | 9747B | S | Y | N | ORAL | 2 | 200 | 5 | 69 | PF | 100 | 100 | N | 293.77 | 293.77 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2011-06-01 | N | N | 3,671 |
9748C_7276_1184_5396_6477 | Sirolimus | Sirolimus | Tablet 0.5 mg | sirolimus 500 microgram tablet, 100 | Rapamune | HS | 9748C | S | Y | N | ORAL | 2 | 200 | 5 | 69 | PF | 100 | 100 | N | 293.77 | 293.77 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2011-06-01 | N | N | 3,671 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.